{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:58:14Z","timestamp":1785862694627,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T00:00:00Z","timestamp":1226361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00125-008-1185-7","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T14:09:55Z","timestamp":1226326195000},"page":"145-153","source":"Crossref","is-referenced-by-count":67,"title":["Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets"],"prefix":"10.1007","volume":"52","author":[{"given":"J.","family":"Udayasankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zraika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Aston-Mourney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Faulenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,11]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM200007273430409","volume":"343","author":"RP Robertson","year":"2000","unstructured":"Robertson RP (2000) Successful islet transplantation for patients with diabetes\u2014fact or fantasy? N Engl J Med 343:289\u2013290","journal-title":"N Engl J Med"},{"key":"1185_CR2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"AM Shapiro","year":"2000","unstructured":"Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230\u2013238","journal-title":"N Engl J Med"},{"key":"1185_CR3","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","volume":"54","author":"EA Ryan","year":"2005","unstructured":"Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060\u20132069","journal-title":"Diabetes"},{"key":"1185_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.TP.0000054618.03927.70","volume":"76","author":"HA Clayton","year":"2003","unstructured":"Clayton HA, Davies JE, Pollard CA, White SA, Musto PP, Dennison AR (2003) Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leicester General Hospital. Transplantation 76:92\u201398","journal-title":"Transplantation"},{"key":"1185_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00400722","volume":"38","author":"P Westermark","year":"1995","unstructured":"Westermark P, Eizirik DL, Pipeleers DG, Hellerstrom C, Andersson A (1995) Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38:543\u2013549","journal-title":"Diabetologia"},{"key":"1185_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/2000-1967-113","volume":"108","author":"GT Westermark","year":"2003","unstructured":"Westermark GT, Westermark P, Nordin A, Tornelius E, Andersson A (2003) Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci 108:193\u2013203","journal-title":"Ups J Med Sci"},{"key":"1185_CR7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMc0802893","volume":"359","author":"GT Westermark","year":"2008","unstructured":"Westermark GT, Westermark P, Berne C, Korsgren O (2008) Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med 359:977\u2013979","journal-title":"N Engl J Med"},{"key":"1185_CR8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11892-005-0007-2","volume":"5","author":"P Westermark","year":"2005","unstructured":"Westermark P, Andersson A, Westermark GT (2005) Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets? Curr Diab Rep 5:184\u2013188","journal-title":"Curr Diab Rep"},{"key":"1185_CR9","first-page":"801","volume":"35","author":"ET Bell","year":"1959","unstructured":"Bell ET (1959) Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol 35:801\u2013805","journal-title":"Am J Pathol"},{"key":"1185_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00403322","volume":"33","author":"A Clark","year":"1990","unstructured":"Clark A, Saad MF, Nezzer T et al (1990) Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia 33:285\u2013289","journal-title":"Diabetologia"},{"key":"1185_CR11","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/diabetes.52.11.2759","volume":"52","author":"HL Zhao","year":"2003","unstructured":"Zhao HL, Lai FM, Tong PC et al (2003) Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 52:2759\u20132766","journal-title":"Diabetes"},{"key":"1185_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/03009734000000014","volume":"77","author":"P Westermark","year":"1972","unstructured":"Westermark P (1972) Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci 77:91\u201394","journal-title":"Ups J Med Sci"},{"key":"1185_CR13","first-page":"151","volume":"9","author":"A Clark","year":"1988","unstructured":"Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased A-cells, reduced B cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151\u2013159","journal-title":"Diabetes Res"},{"key":"1185_CR14","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O\u2019Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A 84:3881\u20133885","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1185_CR15","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 84:8628\u20138632","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1185_CR16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn SE, D\u2019Alessio DA, Schwartz MW et al (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39:634\u2013638","journal-title":"Diabetes"},{"key":"1185_CR17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756\u2013760","journal-title":"Nature"},{"key":"1185_CR18","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1074\/jbc.271.4.1988","volume":"271","author":"TA Mirzabekov","year":"1996","unstructured":"Mirzabekov TA, Lin MC, Kagan BL (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271:1988\u20131992","journal-title":"J Biol Chem"},{"key":"1185_CR19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491\u2013498","journal-title":"Diabetes"},{"key":"1185_CR20","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","volume":"273","author":"B Konarkowska","year":"2006","unstructured":"Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ (2006) The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J 273:3614\u20133624","journal-title":"FEBS J"},{"key":"1185_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/db06-0734","volume":"56","author":"RA Ritzel","year":"2007","unstructured":"Ritzel RA, Meier JJ, Lin CY, Veldhuis JD, Butler PC (2007) Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes 56:65\u201371","journal-title":"Diabetes"},{"key":"1185_CR22","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C (1990) Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A 87:5036\u20135040","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1185_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0014-5793(93)81444-5","volume":"323","author":"N Fox","year":"1993","unstructured":"Fox N, Schrementi J, Nishi M et al (1993) Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 323:40\u201344","journal-title":"FEBS Lett"},{"key":"1185_CR24","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/BF00400803","volume":"36","author":"JW Hoppener","year":"1993","unstructured":"Hoppener JW, Verbeek JS, de Koning EJ et al (1993) Chronic overproduction of islet amyloid polypeptide\/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia 36:1258\u20131265","journal-title":"Diabetologia"},{"key":"1185_CR25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2337\/diab.43.12.1457","volume":"43","author":"DA D\u2019Alessio","year":"1994","unstructured":"D\u2019Alessio DA, Verchere CB, Kahn SE et al (1994) Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes 43:1457\u20131461","journal-title":"Diabetes"},{"key":"1185_CR26","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler AE, Janson J, Soeller WC, Butler PC (2003) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304\u20132314","journal-title":"Diabetes"},{"key":"1185_CR27","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere CB, D\u2019Alessio DA, Palmiter RD et al (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A 93:3492\u20133496","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1185_CR28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","volume":"52","author":"RL Hull","year":"2003","unstructured":"Hull RL, Andrikopoulos S, Verchere CB et al (2003) Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52:372\u2013379","journal-title":"Diabetes"},{"key":"1185_CR29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2337\/db06-0430","volume":"56","author":"S Zraika","year":"2007","unstructured":"Zraika S, Hull RL, Udayasankar J et al (2007) Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis. Diabetes 56:304\u2013310","journal-title":"Diabetes"},{"key":"1185_CR30","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2337\/diabetes.50.11.2514","volume":"50","author":"F Wang","year":"2001","unstructured":"Wang F, Hull RL, Vidal J, Cnop M, Kahn SE (2001) Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes 50:2514\u20132520","journal-title":"Diabetes"},{"key":"1185_CR31","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00125-005-1772-9","volume":"48","author":"RL Hull","year":"2005","unstructured":"Hull RL, Kodama K, Utzschneider KM, Carr DB, Prigeon RL, Kahn SE (2005) Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation. Diabetologia 48:1350\u20131358","journal-title":"Diabetologia"},{"key":"1185_CR32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diabetes.52.7.1701","volume":"52","author":"RA Ritzel","year":"2003","unstructured":"Ritzel RA, Butler PC (2003) Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 52:1701\u20131708","journal-title":"Diabetes"},{"key":"1185_CR33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2337\/diab.45.9.1161","volume":"45","author":"AM Davalli","year":"1996","unstructured":"Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC (1996) Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45:1161\u20131167","journal-title":"Diabetes"},{"key":"1185_CR34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3727\/000000002783985251","volume":"11","author":"PO Carlsson","year":"2002","unstructured":"Carlsson PO, Mattsson G (2002) Oxygen tension and blood flow in relation to revascularization in transplanted adult and fetal rat pancreatic islets. Cell Transplant 11:813\u2013820","journal-title":"Cell Transplant"},{"key":"1185_CR35","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1210\/jc.2002-020728","volume":"87","author":"PO Carlsson","year":"2002","unstructured":"Carlsson PO, Palm F, Mattsson G (2002) Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab 87:5418\u20135423","journal-title":"J Clin Endocrinol Metab"},{"key":"1185_CR36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diab.38.4.510","volume":"38","author":"O Korsgren","year":"1989","unstructured":"Korsgren O, Jansson L, Andersson A (1989) Effects of hyperglycemia on function of isolated mouse pancreatic islets transplanted under kidney capsule. Diabetes 38:510\u2013515","journal-title":"Diabetes"},{"key":"1185_CR37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI116297","volume":"91","author":"E Montana","year":"1993","unstructured":"Montana E, Bonner-Weir S, Weir GC (1993) Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL\/6 mice. J Clin Invest 91:780\u2013787","journal-title":"J Clin Invest"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-1185-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-008-1185-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-008-1185-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:47:07Z","timestamp":1558612027000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-008-1185-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s00125-008-1185-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,11]]}}}